QIAGEN had the pleasure of taking part in an NGS Bioinformatics Challenge run by the German Society for Pathology on the 9th and 10th of November in Halle, Germany. Three commercial organizations were supplied with vcf files from twelve samples sequenced using Illumina MiSeq™ Systems and the IonTorrent platform at Erlangen, Cologne Berlin. The identity of the know variants were withheld from all competing commercial informatics pipelines and the samples were supplied to each competitor one week before the meeting.
Susana Guedes represented QIAGEN at the NGS Bioinformatics Challenge and will demonstrate the process to result for one of the samples in this video. The analysis is performed using QIAGEN’s Clinical Insight-Interpret (QCI I), the NGS clinical decision support tool for variant interpretation and reporting.
QIAGEN’s Clinical Insight (QCI) has recently been updated to enable the automatic classification of somatic cancer alterations for actionability according to the AMP/ASCO/CAP interpretation and reporting guidelines!
